trending Market Intelligence /marketintelligence/en/news-insights/trending/qwkZ2oHMFPUArbCFb0y2wQ2 content esgSubNav
In This List

Boston Biomedical appoints chief medical officer, chief commercial officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Boston Biomedical appoints chief medical officer, chief commercial officer

Boston Biomedical Inc. appointed Edgar Braendle as executive vice president, head of research and development and chief medical officer.

Braendle previously served as president and CEO of ARUP Laboratories, a national clinical and anatomic pathology reference laboratory.

The company also appointed Dee Mahoney as senior vice president and chief commercial officer.

Mahoney was previously the co-founder and president of DMH BioPharm Advisors, a boutique management consultancy.

Boston Biomedical is owned by Sumitomo Dainippon Pharma Co. Ltd.